Stress Perfusion CMR Imaging-Guided Management and Prognosis in Patients With Suspected Coronary Heart Disease

View at publisher
Authors: Antonin Trimaille, Philippe Garot, Solenn Toupin, Francesca Sanguineti, Thomas Hovasse, Suzanne Duhamel, Stéphane Champagne, Thierry Unterseeh, Mariama Akodad, Antoinette M. Neylon, Lounis Hamzi, Trecy Goncalves
+15 more Andreea Sorina Afana, Alexandre Unger, Jeremy Florence, Emmanuel Gall, Paul-Jun Martial, Alexandre Pfeffer, Elena Sofia Canuti, A. Kante, Manveer Singh, Jean Guillaume Dillinger, Patrick Henry, Olivier Morel, V. Bousson, Jérôme Garot, Theo Pezel
Cited by: 1
References: 23

Abstract

BACKGROUND: Identifying patients with chronic coronary syndrome who will benefit most from a coronary revascularization strategy is essential. Data on the performance of stress cardiac magnetic resonance (CMR) to guide revascularization are limited. To assess the long-term prognostic impact of stress CMR-guided revascularization strategy to predict all-cause death. METHODS: We conducted an observational study including all consecutive patients who underwent stress CMR for suspected or known chronic coronary syndrome in 3 centers in France. CMR-guided coronary revascularization was defined as any revascularization performed within 90 days following stress CMR. The primary outcome was all-cause death. RESULTS: A total of 50 701 patients were included (mean age, 64±12 years; 68.5% men). After a median follow-up of 7.2 years (interquartile range, 3.0–11.0), 3665 (7.2%) patients died. Among the 7396 patients with ischemia, 6523 (88%) underwent revascularization. Ischemia and late gadolinium enhancement (LGE) without viability were independent predictors of death (adjusted hazard ratio, 3.67 [99.5% CI, 3.15–4.27] and adjusted hazard ratio, 1.26 [99.5% CI, 1.10–1.44], respectively; P

Fields of Study & Subjects

Cardiac Imaging and Diagnostics Advanced MRI Techniques and Applications Coronary Interventions and Diagnostics

Publication details

Journal / source
Circulation Cardiovascular Interventions
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
19
Issue
3
Pages
e015765–e015765
Publication date
29 January 2026
Language
EN